Effect of interferon beta-1a (Avonex) on changes of non-conventional MRI [magnetic resonance imaging] measures in patients with relapsing-remitting and secondary-progressive multiple sclerosis
Phase of Trial: Phase IV
Latest Information Update: 04 Jun 2015
At a glance
- Drugs Interferon beta-1a (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 06 Jul 2007 New trial record.